NECTIN4 and posterior cortical atrophy: Building upon these insights and supported by our promising in vitro results, which indicated a potential application of EV in PCa patients with NECTIN‐4 overexpression, we systematically investigated diverse metastatic sites, encompassing bone, lymph node and visceral metastases.